Healthcare providers should consider screening for primary aldosteronism (PA) in most patients with hypertension, according to a new Scientific Statement from the Endocrine Society .
Approximately 15 per cent of hypertensive patients have secondary hypertension. Half of children with hypertension and almost a third of adults younger than 40 years have a secondary cause. PA is now considered the most common specifically treatable and potentially curable form of hypertension, accounting for at least 5-10 per cent of cases, even in normokalemic patients. Hypertension can be the initial clinical presentation for at least 14 other endocrine disorders.
The new guidance from the Endocrine Society advises on when to consider testing for endocrine hypertension, and how to interpret test results.
“Without appropriate lab tests, some common endocrine disorders are nearly indistinguishable from a routine case of hypertension,” said Dr William F. Young Jr, Endocrine Society Past President and chair of the task force that developed the Scientific Statement. “Screening for underlying causes of high blood pressure can save lives. This new resource offers healthcare providers valuable guidance on when to suspect a hormone disorder and how to test for it.”